0000912282-24-000578.txt : 20240820
0000912282-24-000578.hdr.sgml : 20240820
20240820111018
ACCESSION NUMBER: 0000912282-24-000578
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220404
FILED AS OF DATE: 20240820
DATE AS OF CHANGE: 20240820
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Wijnker Dennis
CENTRAL INDEX KEY: 0001902668
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39785
FILM NUMBER: 241223427
MAIL ADDRESS:
STREET 1: 536 FIFTH AVENUE
STREET 2: SUITE 400
CITY: NEW YORK
STATE: NY
ZIP: 10001
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: LifeMD, Inc.
CENTRAL INDEX KEY: 0000948320
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE [8011]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 760238453
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 236 FIFTH AVENUE
STREET 2: SUITE 400
CITY: NEW YORK
STATE: NY
ZIP: 10001
BUSINESS PHONE: (866) 351-5907
MAIL ADDRESS:
STREET 1: 236 FIFTH AVENUE
STREET 2: SUITE 400
CITY: NEW YORK
STATE: NY
ZIP: 10001
FORMER COMPANY:
FORMER CONFORMED NAME: CONVERSION LABS, INC.
DATE OF NAME CHANGE: 20180622
FORMER COMPANY:
FORMER CONFORMED NAME: Immudyne, Inc.
DATE OF NAME CHANGE: 20120514
FORMER COMPANY:
FORMER CONFORMED NAME: IMMUDYNE INC
DATE OF NAME CHANGE: 19950720
4
1
form4.xml
X0508
4
2022-04-04
0000948320
LifeMD, Inc.
LFMD
0001902668
Wijnker Dennis
536 FIFTH AVENUE
SUITE 400
NEW YORK
NY
10001
true
Chief Technology Officer
false
Common Stock
2022-04-04
4
A
0
20000
A
20000
D
Common Stock
2024-08-18
4
A
0
80000
A
100000
D
Stock Option (Right to Buy)
3.78
2024-08-18
4
D
0
80000
D
Common Stock
80000
0
D
The restricted shares vest in full on April 4, 2025.
The options are being cancelled in exchange for 205,000 restricted shares, with 40,000 shares vesting on January 1, 2025; 40,000 shares vesting on January 1, 2026; and a remaining 125,000 performance shares to be reported on settlement. The options vest and become exercisable in equal monthly tranches, based on passage of time, over the 36 months following the grant date December 29, 2021.
/s/ Dennis Wijnker
2024-08-19